The use of cefotaxime in the treatment of gram-positive pneumonias

S. G. Jenkinson

Research output: Contribution to journalArticlepeer-review

6 Scopus citations


A single-blind, prospective, randomized comparison of cefotaxime and cefazolin was conducted in 356 patients with gram-positive pneumonias. Clinical cure was achieved in 95.9% of patients receiving cefotaxime and 94% of patients receiving cefazolin. In a sub-group of patients with Staphylococcus aureus pneumonia, clinical cure was obtained in 31 of 37 patients treated with cefotaxime and all of six patients treated with cefazolin. Cefotaxime was well tolerated, safe, and efficacious. These data support the use of cefotaxime as an initial single antibiotic in treating patients with gram-positive pneumonias due to susceptible organisms.

Original languageEnglish (US)
Pages (from-to)S14-S17
Issue number1 Supplement
StatePublished - Jan 1985
Externally publishedYes

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases


Dive into the research topics of 'The use of cefotaxime in the treatment of gram-positive pneumonias'. Together they form a unique fingerprint.

Cite this